Related Experiment Video
Updated: May 28, 2026

10:20
Interview: HIV-1 Proviral DNA Excision Using an Evolved Recombinase
Published on: June 16, 2008
New approaches in HIV eradication research.
1Peter Medawar Building for Pathogen Research, Nuffield Department of Medicine, University of Oxford, Oxford, UK. john.frater@ndm.ox.ac.uk
Current Opinion in Infectious Diseases
|October 18, 2011
Summary
Researchers are exploring new strategies to eradicate human immunodeficiency virus (HIV). Advances in understanding the HIV viral reservoir are paving the way for potential cures, with some novel therapies entering clinical trials.
Area of Science:
- Virology
- Immunology
- Gene Therapy
Background:
- Highly active antiretroviral therapy (HAART) has significantly reduced HIV-related mortality and morbidity.
- Longer-term strategies for HIV management are less defined, prompting renewed interest in HIV eradication.
- Understanding the HIV viral reservoir is crucial for developing effective cure strategies.
Purpose of the Study:
- To review the major obstacles in achieving an HIV cure.
- To highlight key advances and novel strategies for HIV eradication.
- To discuss the progression of research from in vitro studies to clinical trials.
Main Methods:
- Exploration of various eradication approaches including histone modification, immunotoxins, gene therapy, and gene knockout strategies.
- In vitro and animal model studies to assess the efficacy of novel therapies.
- Clinical trials investigating new approaches like histone deacetylase inhibitors and zinc finger nucleases.
Main Results:
- Characterization of the HIV viral reservoir has improved understanding of eradication potential.
- Several novel approaches have shown promise in preclinical studies.
- New strategies, including histone deacetylase inhibitors and zinc finger nucleases, are now in clinical trials.
Conclusions:
- While a definitive cure for HIV remains elusive, significant progress has been made.
- A resurgence of interest in HIV eradication is evident, driven by innovative therapeutic strategies.
- Several promising new approaches have advanced to clinical trial stages, offering hope for a future cure.
Related Concept Videos
Retrovirus Life Cycles
Retroviruses have a single-stranded RNA genome that undergoes a special form of replication. Once the retrovirus has entered the host cell, an enzyme called reverse transcriptase synthesizes double-stranded DNA from the retroviral RNA genome. This DNA copy of the genome is then integrated into the host’s genome inside the nucleus via an enzyme called integrase. Consequently, the retroviral genome is transcribed into RNA whenever the host’s genome is transcribed, allowing the retrovirus to...
Antiviral Nucleoside Inhibitors
Antiviral Nucleoside InhibitorsAntiviral nucleoside inhibitors are structural analogs of natural nucleosides that interfere with viral DNA or RNA synthesis. These compounds selectively target viral polymerases due to their resemblance to host nucleosides, thereby disrupting viral genome replication.Mechanism of Acyclovir ActionAcyclovir is a guanosine analog with a three-carbon acyclic side chain. It selectively targets herpes simplex virus type 1 (HSV-1), herpes simplex virus type 2 (HSV-2),...
Human Virome
The human body harbors a vast and diverse viral community known as the human virome. The virome includes bacteriophages that infect bacteria, and eukaryotic viruses that infect human cells. Transient dietary and environmental viruses also contribute to this dynamic ecosystem. Estimates suggest the human body may contain on the order of 10¹³ viral particles, though abundance varies widely by body site and detection method.Comprehensive characterization of the virome has become possible only with...

